|
FLVCR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22509999999932E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.00020000000234E-05 |
| Normal-vs-Stage2 |
1.786200E-02 |
| Normal-vs-Stage3 |
1.42339999997798E-06 |
| Normal-vs-Stage4 |
1.577930E-02 |
| Stage1-vs-Stage2 |
3.623800E-01 |
| Stage1-vs-Stage3 |
2.941600E-01 |
| Stage1-vs-Stage4 |
5.359600E-01 |
| Stage2-vs-Stage3 |
1.057240E-01 |
| Stage2-vs-Stage4 |
8.340800E-01 |
| Stage3-vs-Stage4 |
2.434200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19379999999436E-05 |
| Normal-vs-AfricanAmerican |
3.361900E-02 |
| Normal-vs-Asian |
3.983800E-04 |
| Caucasian-vs-AfricanAmerican |
5.104600E-01 |
| Caucasian-vs-Asian |
8.283600E-01 |
| AfricanAmerican-vs-Asian |
3.914400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.375900E-04 |
| Normal-vs-Female |
3.63700000000078E-05 |
| Male-vs-Female |
7.313200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.07049999999742E-05 |
| Normal-vs-Age(41-60Yrs) |
1.74739999999618E-05 |
| Normal-vs-Age(61-80Yrs) |
1.050350E-02 |
| Normal-vs-Age(81-100Yrs) |
2.338100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.571000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.542620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.335590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.403900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.015800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.841800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.199900E-04 |
| Classical-VS-Follicular |
1.627550E-01 |
| Classical-VS-Other |
6.952200E-01 |
| Classical-VS-Normal |
1.102920E-03 |
| Tall-VS-Follicular |
8.291700E-02 |
| Tall-VS-Other |
2.792000E-01 |
| Tall-VS-Normal |
5.86339999886221E-08 |
| Follicular-VS-Other |
9.427600E-01 |
| Follicular-VS-Normal |
1.196110E-04 |
| Other-VS-Normal |
6.031600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.86919999999913E-05 |
| Normal-vs-N1 |
2.39269999999792E-05 |
| N0-vs-N1 |
4.564600E-01 |
|
|
